190 related items for PubMed ID: 18618150
21. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
22. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I, Visvardis G, Papadopoulou D, Nakopolou L, Karanikas E, Gogos K, Stavianoudakis G.
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[Abstract] [Full Text] [Related]
23. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
24. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[Abstract] [Full Text] [Related]
25. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome.
Yap HK, Han EJ, Heng CK, Gong WK.
Pediatr Nephrol; 2001 Dec; 16(12):1049-52. PubMed ID: 11793098
[Abstract] [Full Text] [Related]
26. Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study.
Dossier C, Delbet JD, Boyer O, Daoud P, Mesples B, Pellegrino B, See H, Benoist G, Chace A, Larakeb A, Hogan J, Deschênes G.
Pediatr Nephrol; 2019 Apr; 34(4):671-678. PubMed ID: 30552564
[Abstract] [Full Text] [Related]
27. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.
Ulinski T, Aoun B.
Curr Med Chem; 2010 Apr; 17(9):847-53. PubMed ID: 20156172
[Abstract] [Full Text] [Related]
28. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
[Abstract] [Full Text] [Related]
29. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
Xia ZK, Liu GL, Gao YF, Fu J, Fu YF, Zhang LF, Fan ZM.
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885
[Abstract] [Full Text] [Related]
30. New treatment strategies in idiopathic nephrotic syndrome.
Ulinski T, Aoun B.
Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
[Abstract] [Full Text] [Related]
31. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
32. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
33. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Habashy D, Craig JC.
Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003594. PubMed ID: 16625586
[Abstract] [Full Text] [Related]
34. Nephrotic syndrome in children: risk factors for steroid dependence.
Jellouli M, Brika M, Abidi K, Ferjani M, Naija O, Hammi Y, Gargah T.
Tunis Med; 2016 Jul 19; 94(7):401-405. PubMed ID: 28051228
[Abstract] [Full Text] [Related]
35. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P, Bagga A, Jindal N, Srivastava RN.
Pediatr Nephrol; 2001 Nov 19; 16(11):901-5. PubMed ID: 11685598
[Abstract] [Full Text] [Related]
36. Cyclosporine in the treatment of steroid-dependent and steroid-resistant idiopathic nephrotic syndrome in children.
Garcia C, Michelon T, Barros V, Mota D, Uhlmann A, Randon R, Ramalho H, Abbud Filho M.
Transplant Proc; 1998 Dec 19; 30(8):4156-7. PubMed ID: 9865332
[No Abstract] [Full Text] [Related]
37. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May 19; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
38. Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome.
Vivarelli M, Moscaritolo E, Tsalkidis A, Massella L, Emma F.
J Pediatr; 2010 Jun 19; 156(6):965-971. PubMed ID: 20223477
[Abstract] [Full Text] [Related]
39. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.
Sümegi V, Haszon I, Bereczki C, Papp F, Túri S.
Pediatr Nephrol; 2008 Jul 19; 23(7):1085-92. PubMed ID: 18324421
[Abstract] [Full Text] [Related]
40. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 19; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
